The new modalities of treating nephrotic syndrome, chronic renal insuf
ficiencies, renal osteodystrophy and the use of recombinant human grow
th hormone and insulin-like growth factors are reviewed in order to pr
ovide the nephrologist caring for children an informed choice of thera
pies.